<DOC>
	<DOC>NCT02133937</DOC>
	<brief_summary>This single-center, randomized open-label, single-dose, parallel group study will investigate the relative bioavailability of a high concentration liquid formulation (HCLF) versus the reference lyophilized formulation (LyoF) of gantenerumab. Healthy volunteers will be randomized 1:1 to receive single-dose gantenerumab by subcutaneous injection.</brief_summary>
	<brief_title>A Study Investigating the Bioavailability of a High Concentration Liquid Formulation Versus a Reference Lyophilized Formulation of Gantenerumab in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Antibodies, Monoclonal</mesh_term>
	<criteria>Healthy male and female subjects, 40 to 70 years of age inclusive. Healthy status is defined by absence of evidence any active or chronic disease following a detailed medical and surgical history, a complete physical examination including vital signs, 12lead ECG, hematology, blood chemistry, coagulation, serology and urinalysis. Some medical conditions are allowed that are well controlled by single stable medication A BMI between 18.0 to 30.0 kg/m2 inclusive Use of highly effective contraception until 6 months after study followup visit Agree not to donate blood or blood products for transfusion for the duration of the study and for one year after their dosing Suspicion of alcohol or drugs abuse addiction using DSM IV criteria Regular smoker (&gt; 5 cigarettes, &gt; 1 pipeful or &gt; 1 cigar per day), tobacco users and subjects on nicotine replacement therapy Prior administration of gantenerumab Participation in an investigational drug or device study within 60 days before dosing Donation of blood over 500 mL within three months before dosing Pregnancy or breastfeeding Any abnormal skin conditions or potentially obscuring tattoos, pigmentation or lesions in the area intended for subcutaneous injection Any familial history of early onset Alzheimer's disease Claustrophobia, presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, or foreign metal objects in the eyes, skin or body which would contraindicate an MRI scan</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>